Avricore Health Inc.
AVCR.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 3.49M | 3.47M | 3.30M | 2.95M | 2.58M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.49M | 3.47M | 3.30M | 2.95M | 2.58M |
Cost of Revenue | 2.12M | 2.15M | 2.11M | 1.85M | 1.69M |
Gross Profit | 1.37M | 1.32M | 1.19M | 1.09M | 890.40K |
SG&A Expenses | 1.24M | 1.19M | 1.15M | 1.28M | 1.32M |
Depreciation & Amortization | 2.20K | 1.90K | 1.90K | 2.00K | 1.70K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.36M | 3.34M | 3.26M | 3.14M | 3.02M |
Operating Income | 130.90K | 126.60K | 40.30K | -192.00K | -436.20K |
Income Before Tax | -475.80K | 77.00K | -4.20K | -255.30K | -521.90K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.48 | 0.08 | 0.00 | -0.26 | -0.52 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -475.80K | 77.00K | -4.20K | -255.30K | -521.90K |
EBIT | 130.90K | 126.60K | 40.30K | -192.00K | -436.20K |
EBITDA | 451.00K | 459.40K | 380.10K | 134.50K | -131.30K |
EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 401.25M | 399.68M | 398.92M | 398.68M | 398.23M |
Average Diluted Shares Outstanding | 406.98M | 405.41M | 404.66M | 398.68M | 398.23M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |